🇺🇸 FDA
Patent

US 8030285

Oligodeoxynucleotide and its use to induce an immune response

granted A61KA61K2039/55561A61K31/7088

Quick answer

US patent 8030285 (Oligodeoxynucleotide and its use to induce an immune response) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/55561, A61K31/7088, A61K38/00, A61K39/008